Viewing Study NCT02619435


Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2026-02-25 @ 11:47 PM
Study NCT ID: NCT02619435
Status: UNKNOWN
Last Update Posted: 2023-03-24
First Post: 2015-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
Sponsor: National Cancer Institute, Naples
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module